Literature DB >> 16672408

Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation.

A Garcia-Diaz1, G S Clewley, C L Booth, W Labett, N McAllister, A M Geretti.   

Abstract

The performance of the new Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for HIV-1 RNA load determination in plasma was compared to that of the Abbott LCx HIV-1 RNA quantitative assay following automated RNA isolation by the Abbott m1000 extractor. The measured viral loads of 89 clinical specimens differed by mean 0.19 log10 copies/ml (95% confidence interval, 0.12 to 0.26 log10 copies/ml). Although the difference in viral load determinations was positively skewed in favor of the LCx assay, it did not reach statistical significance (P = 0.42). Results were linearly associated (R2 = 0.94) and strongly correlated (R = 0.96). Good performance was observed with HIV-1 subtypes other than B and circulating recombinant forms, although results obtained with two subtype G specimens and one H specimen showed a more substantial difference.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672408      PMCID: PMC1479164          DOI: 10.1128/JCM.44.5.1788-1791.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma.

Authors:  Carmen de Mendoza; José Alcamí; María Sainz; Dolores Folgueira; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay.

Authors:  P Swanson; B J Harris; V Holzmayer; S G Devare; G Schochetman; J Hackett
Journal:  J Virol Methods       Date:  2000-09       Impact factor: 2.014

3.  Comparison of LCx with other current viral load assays for detecting and quantifying human immunodeficiency virus type 1 RNA in patients infected with the circulating recombinant form A/G (CRF02).

Authors:  Alessandra Amendola; Licia Bordi; Claudio Angeletti; Enrico Girardi; Giuseppe Ippolito; Maria R Capobianchi
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

4.  HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003.

Authors:  E Lospitao; A Alvarez; V Soriano; A Holguín
Journal:  HIV Med       Date:  2005-09       Impact factor: 3.180

5.  Subtype-specific problems with quantification of plasma HIV-1 RNA.

Authors:  A Alaeus; K Lidman; A Sönnerborg; J Albert
Journal:  AIDS       Date:  1997-06       Impact factor: 4.177

6.  Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT.

Authors:  Priscilla Swanson; Carmen de Mendoza; Yagnya Joshi; Alan Golden; Richard L Hodinka; Vincent Soriano; Sushil G Devare; John Hackett
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes.

Authors:  N L Michael; S A Herman; S Kwok; K Dreyer; J Wang; C Christopherson; J P Spadoro; K K Young; V Polonis; F E McCutchan; J Carr; J R Mascola; L L Jagodzinski; M L Robb
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

8.  Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1.

Authors:  K Triques; J Coste; J L Perret; C Segarra; E Mpoudi; J Reynes; E Delaporte; A Butcher; K Dreyer; S Herman; J Spadoro; M Peeters
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 9.  PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings.

Authors:  Samuel Yang; Richard E Rothman
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

  9 in total
  11 in total

1.  Performance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China.

Authors:  Sihong Xu; Aijing Song; Jianhui Nie; Xiuhua Li; Youchun Wang
Journal:  Mol Diagn Ther       Date:  2010-10-01       Impact factor: 4.074

2.  HIV-1 load comparison using four commercial real-time assays.

Authors:  Thomas Bourlet; Anne Signori-Schmuck; Laurent Roche; Vinca Icard; Henia Saoudin; Mary-Anne Trabaud; Jean-Claude Tardy; Patrice Morand; Bruno Pozzetto; René Ecochard; Patrice André
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

3.  Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load.

Authors:  Orna Mor; Yael Gozlan; Marina Wax; Fernando Mileguir; Avia Rakovsky; Bina Noy; Ella Mendelson; Itzchak Levy
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

4.  Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

Authors:  M Schutten; D Peters; N K T Back; M Beld; K Beuselinck; V Foulongne; A-M Geretti; L Pandiani; C Tiemann; H G M Niesters
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

5.  Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays.

Authors:  Lesley E Scott; Lara D Noble; Jackie Moloi; Linda Erasmus; Willem D F Venter; Wendy Stevens
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

6.  Comparative evaluation of the ExaVir Load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load.

Authors:  Wendy Labbett; Ana Garcia-Diaz; Zoe Fox; Gillian S Clewley; Thomas Fernandez; Margaret Johnson; Anna Maria Geretti
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

7.  Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa.

Authors:  John A Crump; Lesley E Scott; Emma Msuya; Anne B Morrissey; Ekyafyose E Kimaro; John F Shao; Wendy S Stevens
Journal:  J Virol Methods       Date:  2009-09-01       Impact factor: 2.014

8.  Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests.

Authors:  Carolina Garrido; Natalia Zahonero; Angélica Corral; Miguel Arredondo; Vincent Soriano; Carmen de Mendoza
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

9.  Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection.

Authors:  Sarah Fidler; Ashley D Olson; Heiner C Bucher; Julie Fox; John Thornhill; Charles Morrison; Roberto Muga; Andrew Phillips; John Frater; Kholoud Porter
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

10.  Scale-up of Kenya's national HIV viral load program: Findings and lessons learned.

Authors:  Matilu Mwau; Catherine Akinyi Syeunda; Maureen Adhiambo; Priska Bwana; Lucy Kithinji; Joy Mwende; Laura Oyiengo; Martin Sirengo; Caroline E Boeke
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.